Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2022-03-21
2024-07-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gait Training With Cognitive Tasks in Parkinson's Disease
NCT02025517
Efficacy of Pattern Respiratory PNF Associated Aerobic Training on Lung Volumes and 6MWT Test in Parkinson Individuals
NCT02600052
Treadmill in the Rehabilitation of Parkinsonian Gait
NCT03815409
The Effects of Treadmill Versus Agility Training in Parkinson's Disease
NCT00982709
The Effect of Dual Tasking on Physical and Cognitive Functions in Patients With Parkinson Disease
NCT03902990
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Advanced Training Group
This arm will receive a single session treadmill training session in which both cadence and treadmill speed are controlled.
Advanced treadmill walking
Participants will walking on a treadmill for 6 5-minute Blocks. The cadence will be progressively reduced for the first 3 Blocks. Speed will progressively increase during Blocks 4-6 while cadence from Block 3 is maintained.
Traditional Training Group
This arm will receive a single session treadmill training session in which only treadmill speed is controlled.
Traditional treadmill walking
Participants will walking on a treadmill for 6 5-minute Blocks. Participants will walk at self-selected cadence during Blocks 1-3. Speed will progressively increase during Blocks 4-6.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Advanced treadmill walking
Participants will walking on a treadmill for 6 5-minute Blocks. The cadence will be progressively reduced for the first 3 Blocks. Speed will progressively increase during Blocks 4-6 while cadence from Block 3 is maintained.
Traditional treadmill walking
Participants will walking on a treadmill for 6 5-minute Blocks. Participants will walk at self-selected cadence during Blocks 1-3. Speed will progressively increase during Blocks 4-6.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between the ages of 18-89 years old
* Diagnosed with Parkinson's Disease
* Stage 1-3 based on the Hoehn and Yahr
* Able to walk overground more than 15m independently
* Able to walk on a treadmill for at least 15 minutes independently
Exclusion Criteria
* Experience any other known neurologic disorders that affect their ability to walk
* Diagnosed with any visual or communication disorders
* Suffered a lower extremity injury within the last 6 months
18 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Georgia State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Feng Yang, PhD
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Feng Yang, PhD
Role: PRINCIPAL_INVESTIGATOR
Georgia State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Georgia State University
Atlanta, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H22192
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.